ArticleWellcome open research2021

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.

Graham S Cooke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.